









Markets
/
Stocks
/
nasdaq-gdtc
/

CytoMed Therapeutics Ltd

GDTC

1.405USD

-0.155-9.94%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

16.20MMarket Cap

LossP/E TTM



CytoMed Therapeutics Ltd

1.405

-0.155-9.94%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of CytoMed Therapeutics Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-15.90%-1.20M

41.28%-907.29K

-41.14%-1.03M

-278.68%-1.54M

14.10%-730.99K

19.21%-408.00K

-158.71%-850.98K

-35.17%-505.02K

---328.93K

---373.61K

Net income from continuing operations

24.43%-1.10M

47.29%-847.25K

9.25%-1.45M

-116.44%-1.61M

-108.57%-1.60M

1.03%-742.66K

28.07%-765.88K

-97.54%-750.38K

---1.06M

---379.87K

Operating gains losses

-1.50%128.78K

-14.13%129.88K

-13.47%130.74K

6.15%151.25K

20.02%151.09K

20.82%142.49K

9.02%125.88K

17.35%117.93K

--115.47K

--100.50K

Other non-cash items

47.71%-97.16K

-401.31%-148.30K

-126.16%-185.81K

-52.67%49.22K

613.59%710.23K

-16.08%103.98K

-132.13%-138.29K

4220.65%123.90K

--430.42K

--2.87K

Change in working capital

-68.75%84.75K

32.30%-133.33K

1822.05%271.19K

-389.89%-196.93K

105.06%14.11K

1826.31%67.93K

-246.95%-279.09K

103.63%3.53K

--189.93K

---97.11K

-Change in receivables

-212.27%-92.04K

136.95%32.17K

154.24%81.98K

-305.45%-87.07K

48.60%-151.15K

248.50%42.38K

-812.71%-294.05K

66.73%-28.54K

---32.22K

---85.78K

-Change in inventory

----

-51.13%59.99K

49.45%-58.84K

--122.76K

---116.40K

-Change in payables and accrued expense

-47.88%98.62K

-50.65%-165.50K

14.49%189.21K

-529.94%-109.86K

467.00%165.26K

-71.89%25.55K

-145.31%-45.03K

-13.47%90.91K

--99.39K

--105.06K

-Change in other current liabilities

--78.18K

----

Cash from non-recurring investing activities

Cash from operating activities

-15.90%-1.20M

41.28%-907.29K

-41.14%-1.03M

-278.68%-1.54M

14.10%-730.99K

19.21%-408.00K

-158.71%-850.98K

-35.17%-505.02K

---328.93K

---373.61K

Investing cash flow

Net cash from continuing investing activities

2214.28%699.55K

5453.06%708.37K

-21.16%30.23K

-95.95%12.76K

-90.96%38.34K

3016.02%314.91K

351.38%424.19K

-90.02%10.11K

--93.98K

--101.23K

Capital expenditures

2214.28%699.55K

5453.06%708.37K

-21.91%30.23K

-95.95%12.76K

-90.87%38.71K

3016.02%314.91K

351.38%424.19K

-90.02%10.11K

--93.98K

--101.23K

Net cash flow from disposal of fixed assets

1976.07%627.55K

5453.06%708.37K

-21.16%30.23K

-95.95%12.76K

-90.96%38.34K

3016.02%314.91K

434.81%424.19K

-89.94%10.11K

--79.32K

--100.46K

Net cash flow from intangible asset transactions

--72.00K

----

--0.00

----

-100.00%0.00

--14.66K

--763.05

Net cash flow from investment products

--252.96K

----

-100.00%0.00

100.00%0.00

195.93%180.04K

---176.59K

---187.67K

--0.00

Net cash flow from other investing activities

235.18%2.75M

81.23%-760.96K

---2.03M

---4.05M

----

Cash from non-current investing activities

Net cash flow from investing activities

211.58%2.30M

63.87%-1.47M

-5285.17%-2.06M

-1191.29%-4.07M

90.96%-38.34K

-68.67%-314.91K

-50.61%-424.19K

-84.43%-186.70K

---281.65K

---101.23K

Financing cash flow

Cash flow from continuous financing activities

-575.33%-18.99K

-100.19%-15.36K

-99.53%3.99K

28621.89%8.16M

247.78%847.37K

-100.99%-28.62K

-67.84%243.65K

308.91%2.90M

--757.54K

--709.50K

Net cash flow from debt Issuance/repayment

-575.33%-18.99K

94.04%-15.36K

105.90%3.99K

-799.97%-257.59K

-127.77%-67.65K

-10.27%-28.62K

-35.71%243.65K

-103.66%-25.96K

--379.01K

--709.50K

Net cash flow from common stock issuance/repurchase

----

-100.00%0.00

--8.42M

--915.02K

-100.00%0.00

--1.46M

--378.53K

--0.00

Net cash flow from other financing activities

----

--0.00

-100.00%0.00

--0.00

--1.46M

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-575.33%-18.99K

-100.19%-15.36K

-99.53%3.99K

28621.89%8.16M

247.78%847.37K

-100.99%-28.62K

-67.84%243.65K

308.91%2.90M

--757.54K

--709.50K

Net cash flow

Beginning cash balance

-67.86%2.46M

495.07%7.00M

588.62%7.66M

-37.24%1.18M

-61.71%1.11M

189.39%1.87M

457.42%2.91M

143.30%647.84K

--521.47K

--266.27K

Current period cash flow changes

136.41%1.13M

-191.83%-2.34M

-4566.54%-3.09M

432.41%2.54M

106.71%69.27K

-134.73%-765.21K

-793.88%-1.03M

865.57%2.20M

--148.73K

--228.18K

Effect of exchange rate changes

2763.40%37.47K

755.62%56.13K

83.96%-1.41K

37.41%-8.56K

-1748.26%-8.77K

-117.01%-13.68K

-126.80%-474.52

2.80%-6.30K

--1.77K

---6.48K

Ending cash balance

-21.45%3.59M

25.41%4.67M

286.57%4.57M

235.27%3.72M

-36.94%1.18M

-61.08%1.11M

179.73%1.87M

476.61%2.85M

--670.20K

--494.45K

Free cash flow

-78.48%-1.90M

-3.72%-1.62M

-37.97%-1.06M

-115.48%-1.56M

39.64%-769.70K

-40.34%-722.91K

-201.53%-1.28M

-8.48%-515.12K

---422.90K

---474.84K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

